Exposure to high glucose and streptozotocin-induced diabetes models shows that stabilization of RUNX2 depends upon AMPK activation, and our in vitro kinase assays showed that AMPK phosphorylates RUNX2 at S118. Here, RUNX2 is linked to diabetes mellitus.